Twin Tree Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-33,400
Closed -$4.82M 1562
2025
Q3
$4.82M Sell
33,400
-281,200
-89% -$38.4M 0.02% 763
2025
Q2
$39.8M Buy
+314,600
New +$38.6M 0.07% 266
2025
Q1
Sell
-109,300
Closed -$14.5M 1715
2024
Q4
$14.5M Buy
+109,300
New +$15.4M 0.03% 566
2024
Q3
Sell
-28,700
Closed -$3.94M 1630
2024
Q2
$3.94M Hold
28,700
0.01% 822
2024
Q1
$3.94M Buy
+28,700
New +$3.92M 0.01% 871
2021
Q4
Sell
-360,100
Closed -$58.2M 1694
2021
Q3
$58.2M Buy
+360,100
New +$60.6M 0.13% 146
2020
Q4
Sell
-45,600
Closed -$6.17M 1373
2020
Q3
$6.17M Buy
+45,600
New +$6.19M 0.03% 522
2018
Q4
Sell
-16,000
Closed -$1.95M 1410
2018
Q3
$1.95M Buy
+16,000
New +$1.88M 0.01% 595
2018
Q1
Sell
-9,300
Closed -$993K 1191
2017
Q4
$993K Sell
9,300
-162,000
-95% -$17.3M 0.01% 702
2017
Q3
$19M Hold
171,300
0.15% 136
2017
Q2
$17.7M Buy
171,300
+131,700
+333% +$13M 0.14% 148
2017
Q1
$3.87M Buy
39,600
+36,900
+1,367% +$3.53M 0.04% 398
2016
Q4
$239K Buy
+2,700
New +$246K ﹤0.01% 970

Other funds holding IBB

Twin Tree Management's IBB Position: Q1 2026 in Review

Twin Tree Management opened a new position in iShares Biotechnology ETF (IBB) in Q1 2026: 2,584 shares worth $436K. The stake represents 0.01% of the portfolio and ranks #960 among its holdings. This is a return to the name: Twin Tree Management previously reported a position in IBB as recently as Q1 2025.

Twin Tree Management first reported a position in IBB in Q4 2016 and has held it in 15 quarters since. The position peaked at $52.3M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Twin Tree Management held 2,584 shares of iShares Biotechnology ETF worth $436K as of Q1 2026.
  • iShares Biotechnology ETF was a new Twin Tree Management position in Q1 2026.
  • iShares Biotechnology ETF made up 0.01% of Twin Tree Management's portfolio in Q1 2026, its #960 holding.
  • Twin Tree Management first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 15 quarters since.
  • Twin Tree Management's iShares Biotechnology ETF position peaked at $52.3M in Q2 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Twin Tree Management's 13F filing for Q1 2026, filed 14 May 2026.